Association of lipoprotein(a) with long‐term mortality following coronary angiography or percutaneous coronary intervention

Background There is no consistent evidence to suggest the association of plasma lipoprotein(a) (Lp[a]) with long‐term mortality in patients undergoing coronary angiography (CAG) or percutaneous coronary intervention (PCI). Hypothesis Level of Lp(a) is associated with long‐term mortality following CA...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical cardiology (Mahwah, N.J.) N.J.), 2017-09, Vol.40 (9), p.674-678
Hauptverfasser:	Feng, Zhe, Li, Hua‐long, Bei, Wei‐jie, Guo, Xiao‐sheng, Wang, Kun, Yi, Shi‐xin, Luo, De‐mou, Li, Xi‐da, Chen, Shi‐qun, Ran, Peng, Chen, Peng‐yuan, Islam, Sheikh Mohammed Shariful, Chen, Ji‐yan, Liu, Yong, Zhou, Ying‐ling
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Angioplasty Biomarkers - blood Chi-Square Distribution Clinical Investigations Coronary Angiography Coronary Angiography - adverse effects Coronary Angiography - mortality Coronary Artery Disease - blood Coronary Artery Disease - diagnostic imaging Coronary Artery Disease - mortality Coronary Artery Disease - therapy Female Hospital Mortality Humans Kaplan-Meier Estimate Lipoprotein(a) Lipoprotein(a) - blood Male Medical imaging Middle Aged Mortality Multivariate Analysis Percutaneous Coronary Intervention Percutaneous Coronary Intervention - adverse effects Percutaneous Coronary Intervention - mortality Predictive Value of Tests Proportional Hazards Models Retrospective Studies Risk Factors Time Factors Treatment Outcome Up-Regulation
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Background There is no consistent evidence to suggest the association of plasma lipoprotein(a) (Lp[a]) with long‐term mortality in patients undergoing coronary angiography (CAG) or percutaneous coronary intervention (PCI). Hypothesis Level of Lp(a) is associated with long‐term mortality following CAG or PCI. Methods We enrolled 1684 patients with plasma Lp(a) data undergoing CAG or PCI between April 2009 and December 2013. The patients were divided into 2 groups: a low‐Lp(a) group (Lp[a]
ISSN:	0160-9289 1932-8737
DOI:	10.1002/clc.22712